MIRA INFORM REPORT

 

 

Report Date :

10.09.2007

 

IDENTIFICATION DETAILS

 

Name :

HEALTHCAPS INDIA LIMITED

 

 

Formerly Known As :

CAPSUGEL INDIA LIMITED

 

 

Registered Office :

H – 2, 3rd Floor, C – Block, Community Centre, Naraina Vihar, New Delhi – 110028

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

06.12.1982

 

 

Com. Reg. No.:

55-14789

 

 

CIN No.:

[Company Identification No.]

L74899DL1982PLC014789

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

JLDC00783G

 

 

PAN No.:

[Permanent Account No.]

AAACC5021C

 

 

Legal Form :

Closely held Public Limited Liability Company.

 

 

Line of Business :

Manufacturer and Exporter  of Empty Hard Gelatine Capsules

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 150000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office  :

H – 2, 3rd Floor, C – Block, Community Centre, Naraina Vihar, New Delhi – 110028, India

Tel. No.:

91-11-25779661 / 25771526

E-Mail :

heakthcaps@hotmail.com

 

 

Administrative  Office :

Sco. 1134-35, First Floor, Sector 22-B, Chandigarh – 160 022

Tel. No.:

91-172-2706696 / 2708115

Mobile No.:

91-9417213636

Fax No.:

91-1881-273304

 

 

Sales Office :

Kanara Business Centre, Laxmi Nagar, Ghatkopar (E), Mumbai, Maharashtra

Tel No.:

91-22-55995416

Fax No. ;

91-22-55995417

Email :

mumbai@healthcapsindia.com

 

 

Factory :

Fatehpur, P.O. Majra Jattan, Tehsil : Balachaur, District : Nawanshahr, Punjab

Tel No.:

91-1881-273637 / 2736641 / 273303

Fax No.:

91-1881-273304

Email :

info@healthcapsindia.com

Website :

http://www.healthcapsindia.com

 

 

DIRECTORS

 

Name :

Mr. A K Mahajan

Designation :

Chairman cum Managing Director

Address :

House No. 807, Sector 38, Chandigarh

Date of Birth/Age :

07.05.1957 (46 Years)

Qualification :

B.E.

Experience :

20 Years

Date of Appointment :

14.12.1993

 

 

Name :

Mr. Chiranjiv Singh

Designation :

Managing Director

Address :

II 53, Sector 36, Chandigarh

Date of Birth/Age :

25.08.1951 (55 Years)

Qualification :

B.E. Electrical

Experience :

25 Years

Date of Appointment :

01.04.1983

 

 

Name :

Ms. Hariti Singh

Designation :

Director

Address :

II 53, Sector 36, Chandigarh

Date of Birth/Age :

24.04.1955 (52 Years)

Qualification :

BA

Experience :

25 Years

Date of Appointment :

05.01.1997

 

 

Name :

Mr. Yogesh Guel

Designation :

Director

Address :

House No. 863, Sector 2, Panchkula, Harayana

Date of Birth/Age :

08.06.1960 (45 Years)

Qualification :

B.E.

Experience :

20 Years

Date of Appointment :

27.01.2003

 

 

Name :

Mr. Jagatjit Singh

Designation :

Director

Address :

House No. 2548, Sector 47, Chandigarh, India

Date of Birth/Age :

27.12.1965

Date of Appointment :

27.01.2003

 

 

Name :

Mr. I S Bindra

Designation :

Director

Address :

House No 1017, Sector 27, Chandigarh, India

Date of Birth/Age :

22.12.1940

Date of Appointment :

22.03.2003

 

 

Name :

Mr. Gurcharan Singh

Designation :

Director

Address :

House No 113, Phase 3 B, Mohali, Punjab

Date of Birth/Age :

01.01.1936 (70 Years)

Qualification:

B.E.

Experience :

40 Years

Date of Appointment :

08.02.2000

 

 

SHAREHOLDING PATTERN

 

Names of Shareholders

 

Percentage of Holding

Public financial companies

 

20.00 %

Directors or relatives of directors

 

55.00 %

Other top fifty shareholders

 

25.00 %

Total

 

100.00 %

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Empty Hard Gelatine Capsules

 

 

Products :

Product Description

ITC Code No

Empty Hard Gelatine Capsules

Size ‘0’  , ‘1’ & ‘2’

3503.00

 

 

Exporter  To :

 

Products :

All Products

Country :

USA, Egypt, UK

 

 

Terms :

 

Selling :

Credit ( 9 days)

 

 

Purchasing :

L/C, Credit ( 90 days)

 

PRODUCTION STATUS

 

Particulars

Unit

 

 

Actual Production

Empty Hard Gelatine Capsules 

QTY

 

 

31567

 

 

 

 

 

 

 

GENERAL INFORMATION

 

Customer :

  • Cipla Limited
  • Jagsonpal Pharmaceuticals Limited
  • UPDPL
  • Alkem Limited
  • Lupin Laboratories limited
  • Indichem Limited
  • Mission Pharmaceuticals Limited
  • U.S. Vitamin Limited
  • Wockhardt Limited
  • Dabur India Limited
  • Ajanta Pharma Limited
  • Aristo Pharmaceaticals Limited
  • Maxheal Pharmaceuticals Limited
  • Akums Limited

 

 

No. of Employees :

250 (In Office 50, In Factory 200)

 

 

 

 

Bankers :

State Bank of India

Specialised Commercial Branch

Sco : 103-106, Sector 17 B, Chandigarh – 160017, India

 

Punjab National Bank

 

 

Facilities :

Cash / Credit, Over Draft & L/C Limit, State Bank of India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

V K Chadha and Company

Chartered Accountants

Address :

F – II, South Extension part – II, New Delhi – 110049, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

4,037,190

Equity Shares

Rs. 10/- each

Rs. 40.372 Millions

 

Less Calls in Arrears

 

Rs. 0.095 Millions

 

 

 

Rs. 40.277 Millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

40.277

40.277

40.277

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

45.879

46.966

35.046

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

86.156

87.243

75.323

LOAN FUNDS

 

 

 

1] Secured Loans

76.523

51.145

56.721

2] Unsecured Loans

3.365

4.214

1.875

TOTAL BORROWING

79.888

55.359

58.596

DEFERRED TAX LIABILITIES

17.152

2.823

3.867

 

 

 

 

TOTAL

183.196

145.425

137.786

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

138.146

105.243

102.750

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

14.396

9.997

14.527

 

Sundry Debtors

48.645

42.309

31.338

 

Cash & Bank Balances

5.369

3.463

2.596

 

Other Current Assets

6.597

0.042

0.018

 

Loans & Advances

0.000

2.984

3.456

Total Current Assets

75.007
58.795

51.935

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Current Liabilities

30.129

18.814

17.129

 

Provisions

0.000

 

 

Total Current Liabilities

30.129
18.814

17.129

Net Current Assets

44.878
39.981

34.806

 

 

 

 

MISCELLANEOUS EXPENSES

0.172

0.201

0.230

 

 

 

 

TOTAL

183.196

145.425

137.786

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Sales Turnover

168.175

158.609

130.381

Other Income

0.426

0.938

1.198

Total Income

168.601

159.547

131.579

 

 

 

 

Profit/(Loss) Before Tax

14.855

13.189

16.451

Provision for Taxation

0.351

1.270

6.030

Profit/(Loss) After Tax

14.504

11.919

10.421

 

 

 

 

Earnings in Foreign Currency :

 

 

 

 

Export Earnings

13.900

15.261

13.278

Total Earnings

13.900

15.261

13.278

 

 

 

 

Expenditures :

 

 

 

 

Capital Goods

1.646

1.206

0.000

 

Administrative Expenses

12.797

10.802

0.000

 

Selling Expenses

132.273

115.168

0.000

 

Raw Material Consumed

0.000

0.000

42.390

 

Consumption of stores and spares parts

0.000

0.000

4.904

 

Increase/(Decrease) in Finished Goods

0.000

0.000

[6.302]

 

Salaries, Wages, Bonus, etc.

0.000

0.000

13.238

 

Managerial Remuneration

0.000

0.000

1.253

 

Payment to Auditors

0.000

0.000

0.106

 

Interest

9.464

6.394

3.314

 

Insurance Expenses

0.000

0.000

0.543

 

Power & Fuel

0.000

0.000

13.141

 

Depreciation & Amortization

8.394

7.061

6.254

 

Other Expenditure

0.000

0.000

36.287

Total Expenditure

164.574

140.631

115.128

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

8.60

7.47

7.92

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

8.83

8.32

12.62

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

6.96

8.04

10.64

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.17

0.15

0.22

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.27

0.85

1.01

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.48

3.13

3.03

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Fixed Assets

 

Ø       Factory Building

Ø       Land

Ø       Plant and Machinery

Ø       Furniture and Fixture

Ø       Office Equipments

Ø       Electrical Fittings

Ø       Laboratory Equipments

Ø       Workshop Equipments

Ø       Vehicles

 

 

Bankers Charges Report as per Registry

 

Name of the company

CAPSUGEL INDIA LIMITED

Presented By

Mr. Chiranjiv Singh, Managing Director

1) Date and description of instrument creating the change

03.05.1994, Cash Credit [Bill Discount] agreement

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 0.950 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Against Drafts / Bill of Exchange whatever may be tenure thereof drawn accepted or endorsed by the company with  or without documents.

4) Gist of the terms and conditions and extent and operation of the charge.

Second charge on fixed assets.

 

Rate of interest is 5 % p.a. below minimum landing

Repayable on demand

Margin 15 % 

5) Name and Address and description of the person entitled to the charge.

State Bank of India

Ropar, Punjab

6) Date  and brief description of instrument modifying the charge

Nil

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Nil

 

This form is for

Modification of charge

Charge identification number of the charge to be modified

10000452

Corporate identity number of the company

L74899DL1982PLC014789

Name of the company

CAPSUGEL INDIA LIMITED

Address of the registered office or of the principal place of  business in India of the company

H – 2, 3rd Floor, C – Block, Community Centre, Naraina Vihar, New Delhi – 110028

Type of charge

Immovable property

Book Debts

Movable Property 

Particular of charge holder

State Bank of India

Specialised Commercial Branch

Sco : 103-106, Sector 17 B, Chandigarh – 160017, India

Sbi.09926@sbi.co.in

Nature of description of the instrument creating or modifying the charge

Agreement of Hyp. Of goods and assets dated 02.02.2006; Letter regarding the grant of Individual limits with in Overall Limit dated 02.02.2006 regd. With ROC on 16.04.2006 for credit facilities of Rs. 57.500 Millions; Modified on 16.06.2006; Regd with ROC on 17.08.2006; Credit facilities increased from RS. 57.500 Millions to Rs. 89.500 Millions. Now modified Supp. Ag. of Hyp. Of Goods and assets for increase in the overall limit and letter regarding the grant of individual limits with in overall limit

Date of instrument Creating the charge

08.03.2007

Amount secured by the charge

Rs. 101.000 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Cash Credit Hyp : 2 % above SBAR at present 14.25 % with monthly rest

 

Term Loan – I & II Existing : 1.25 % above SBAR

Term Loan III 1.25 %5 above SBAR

Term Loan Computer : 1.25 % above SBAR

Short particulars of the property charged

First charge over the assets being created out of the finance and hypothecation of Plant and Machinery and other Misc. assets as primary security and first charge over the existing movables and immovable assets of the company present and   future in favour of Bank and the charge to be extended over the security already charged in favour of Bank in respect of respect of existing facilities as collateral security and the total charge has been increased from Rs. 89.500 Millions to Rs. 101 Millions  

Date of latest modification prior to the present modification

16.06.2006

Particulars of the present modification 

Supplemental agreement of Hyp. Of Goods and assets for increase in the overall limits and letter regarding the grant of individual limits with in overall limit dated 08.03.2007

Credit facilities increased from Rs. 89.500 Millions to Rs. 101 Millions other terms and conditions remain the same.

 

 

CIL, at present, has got a capacity to manufacture 2500 million pieces per annum of High Quality Empty Hard Gelatine Capsules. Presently the capsules in size 0, size 1 and size 2 are being manufactured as per the standards of Indian Pharmacopoeia in all types of colors and shades as per customer requirements. CIL also produces size 0 elongated (0el) as per the requirement of customers. CIL is presently operating 8 machines to achieve the above stated capacity.

 

 

 

Web Details Attached :

 

Note :  Capsugel India Ltd is now Healthcaps India Ltd.

The Company  was incorporated in 1983 to cater to the ever increasing demand of the pharmaceutical industry for hi- quality empty hard gelatin capsules. With the objective of creating an environmental, eco friendly and a state of the art manufacturing facility with stringent quality control checks in place we chose the open spaces of Fatehpur in the neighbouring Punjab state 60 Kms from Chandigarh. And, to ensure easy connectivity with all their clients The company set up offices in New Delhi and Mumbai.

Ever since commencement of operations in 1985 The company has continued to produce and deliver the highest quality of empty hard gelatin capsules to major pharmaceutical clients in India and abroad. Their  technical know how and critical machinery have been imported from the Cherry Burrell Corporation known as Evergreen Packaging U.S.A. Over the years Healthcaps India has maintained its hi-quality in its manufacturing processes and has now emerged as a trusted name in the domestic and global pharmaceutical industry .

 

 

About Company

In the early eighties Chiranjiv Singh a young entrepreneur took an in-depth look at the future of the easy to administer drug possibilities in the rapidly growing pharmaceutical industry in India and abroad. Analysing the existing capacity of that period and envisaging future needs he realized the potential and the pressing need for hi- quality ‘equal to international standards' empty hard gelatine capsules for both the domestic and international pharmaceutical companies. In 1983 Healthcaps India was incorporated to provide hi-quality, hi-reliability empty hard gelatine capsules to the rapidly growing pharma industry.

At its state of the art manufacturing facility a well qualified and dedicated work force ensures timely delivery after meticulous quality control checks of the finished product. Their  office personnel along with their associates and network offices keep in constant touch with the latest developments and changes occurring in gelatine capsule manufacturing techniques and research. Their  marketing offices in New Delhi and Mumbai maintain an efficient relationship with all their clients who are constantly encouraged to give them their feedback on their products to help us improve in any sector that requires betterment. Delivery schedules are strictly met and loopholes promptly plugged if any arise. This focus on client satisfaction, prompt delivery and hi quality has resulted in The company now being recognised and trusted by domestic and global leaders in the pharmaceutical industry. Due to this commitment The company today export our hard gelatine capsules to America, Europe and the African continent.

Trusted Clients

Healthcaps India has over the years built up its reputation by serving a reputed clientele, which now include reputed and multinational pharmaceutical companies. Some of these companies are listed below

M/S. Cipla Ltd.
M/S. Jagsonpal Pharmaceuticals Ltd.
M/S. UPDPL
M/S. Alkem Ltd.
M/S. Lupin Laboratories Ltd.
M/S. Indichemi Ltd.
M/S. Mission Pharmaceuticals Ltd
M/S. U.S Vitamin Ltd
M/s. Wockhardt Ltd
M/s. Dabur India Ltd
M/s. Ajanta Pharma Ltd
M/s. Aristo Pharmaceuticals Ltd -
M/s. Maxheal Pharmaceuticals Ltd
M/s. Akums Ltd.

Today, their exports to the USA, UK , VIETNAM , EGYPT , UKRAINE and other countries on a regular basis comprise around 20% of their existing manufacturing capacity.

 

FUTURE PLANS

As the global pharmaceutical industry continues its rapid growth, Healthcaps India maintains a close watch on changing trends, latest developments and innovative research of the future. The company is at present exploring the HPMC veggie capsules market which has considerable potential by the end of 2007. Their  existing product mix is also being enhanced by the addition of Size “3” by June 2007. On the anvil are also plans for setting up another manufacturing unit in neighbouring Himachal Pradesh to meet the growing demand.

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.63

UK Pound

1

Rs.82.42

Euro

1

Rs.55.96

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions